Founded in October of 2016, SunyBiotech provides high quality and efficient gene editing service in Caenorhabditis elegans (C. elegans) using the CRISPR/Cas9 system, as well as related technical services, including plasmid construction, protein purification, generation of antibodies and others.
We have a team of scientists who are experts on CRISPR/Cas9 gene editing in nematodes and were postdoctoral fellows and graduate students trained in top-notch universities in China and abroad. They have successfully generated more than 1000 genome edited C. elegans strains and have provided precise gene knock-out or knock-in strains to laboratories in universities, research institutes, and enterprises around the world, such as Harvard Medical School, Columbia University, UCLA, UCSF, University of Sydney, MRC Laboratory of Molecular Biology, Max Planck Institute, University of Toronto, National university of Singapore and so on.
Additionally, we are actively cooperating with biotech companies to carry out drug screens and development based on the C. elegans model.
Our objective is to build a hub that connects research institutes and biotech companies all over the world to promote exciting breakthroughs in biomedical research and drug discoveries.